EGFR and neoplasm: In addition, our current study also showed that concurrent radiotherapy with gefitinib is effective in elderly patients with ESCC without EGFR overexpression or mutation, indicating that gefitinib could help to sensitize tumor cells to the effect of radiotherapy.